Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 6/2010

01-11-2010 | Clinical Trial Report

Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?

Authors: Shyamal H. Mehta, John C. Morgan, Kapil D. Sethi

Published in: Current Neurology and Neuroscience Reports | Issue 6/2010

Login to get access

Excerpt

Olanow CW, Rascol O, Hauser R, et al.: A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med 2009, 361:1268–1278. …
Literature
1.
Effect of deprenyl on the progression of disability in early Parkinson disease. The Parkinson Study Group [no authors listed]. N Engl J Med 1989, 321:1364–1371.
2.
Ahlskog JE, Uitti RJ: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction. Neurology 2010, 74:1143–1148.CrossRefPubMed
3.
Clarke CE: Are delayed-start design trials to show neuroprotection in Parkinson’s disease fundamentally flawed? Mov Disord 2008, 23:784–7789.CrossRefPubMed
4.
Schapira A, Albrecht S, Barone P, et al:. Immediate vs. delayed-start pramipexole in early Parkinson’s disease: the PROUD study. Parkinsonism Relat Disord 2009, 15:S2–S81.
5.
Metadata
Title
Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?
Authors
Shyamal H. Mehta
John C. Morgan
Kapil D. Sethi
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Neurology and Neuroscience Reports / Issue 6/2010
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0133-3

Other articles of this Issue 6/2010

Current Neurology and Neuroscience Reports 6/2010 Go to the issue

ReviewPaper

Ocular Motility of Aging and Dementia

ReviewPaper

A Review of Conduction Aphasia

ReviewPaper

Neurologic Consequences of the Immune Reconstitution Inflammatory Syndrome (IRIS)

ReviewPaper

Neurologic and Muscular Complications of the 2009 Influenza A (H1N1) Pandemic

ReviewPaper

Neuro-Ophthalmologic Complications of Syringobulbia

ReviewPaper

Neurogenic Stuttering: Its Reticular Modulation